BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31938218)

  • 1. Knockdown of long non-coding RNA
    Tang H; Hou B; Ye Z; Ling C; Guo Y
    Int J Clin Exp Pathol; 2018; 11(3):1238-1246. PubMed ID: 31938218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AFAP1-AS1 Promotes Proliferation of Pituitary Adenoma Cells through miR-103a-3p to Activate PI3K/AKT Signaling Pathway.
    Tang H; Zhu D; Zhang G; Luo X; Xie W
    World Neurosurg; 2019 Oct; 130():e888-e898. PubMed ID: 31299308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of the long non-coding RNA AFAP1-AS1 affects the proliferation, invasion and survival of tongue squamous cell carcinoma via the Wnt/β-catenin signaling pathway.
    Wang ZY; Hu M; Dai MH; Xiong J; Zhang S; Wu HJ; Zhang SS; Gong ZJ
    Mol Cancer; 2018 Jan; 17(1):3. PubMed ID: 29310682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Noncoding RNA AFAP1-AS1 Promotes Cell Proliferation and Apoptosis of Gastric Cancer Cells via PTEN/p-AKT Pathway.
    Guo JQ; Li SJ; Guo GX
    Dig Dis Sci; 2017 Aug; 62(8):2004-2010. PubMed ID: 28451917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased lncRNA AFAP1-AS1 expression predicts poor prognosis and promotes malignant phenotypes in gastric cancer.
    Feng Y; Zhang Q; Wang J; Liu P
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3842-3849. PubMed ID: 28975981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of LncRNA AFAP1-AS1 predicts poor prognosis and promotes cells proliferation and invasion in gallbladder cancer.
    Ma F; Wang SH; Cai Q; Zhang MD; Yang Y; Ding J
    Biomed Pharmacother; 2016 Dec; 84():1249-1255. PubMed ID: 27810781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA AFAP1-AS1 promotes osteosarcoma progression by regulating miR-497/IGF1R axis.
    Fei D; Zhang X; Lu Y; Tan L; Xu M; Zhang Y
    Am J Transl Res; 2020; 12(5):2155-2168. PubMed ID: 32509208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA AFAP1-antisense RNA 1 promotes the proliferation, migration and invasion of gastric cancer cells and is associated with poor patient survival.
    Zhao H; Zhang K; Wang T; Cui J; Xi H; Wang Y; Song Y; Zhao X; Wei B; Chen L
    Oncol Lett; 2018 Jun; 15(6):8620-8626. PubMed ID: 29805596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of long non-coding RNA AFAP1-AS1 inhibits tumor growth, promotes apoptosis and decreases metastasis in thyroid cancer.
    Dai W; Tian Y; Jiang B; Chen W
    Biomed Pharmacother; 2018 Mar; 99():191-197. PubMed ID: 29331858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulated lncRNA AFAP1-AS1 indicates a poor prognosis and promotes carcinogenesis of breast cancer.
    Ma D; Chen C; Wu J; Wang H; Wu D
    Breast Cancer; 2019 Jan; 26(1):74-83. PubMed ID: 29974352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
    Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
    Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast Cancer.
    Zhang K; Liu P; Tang H; Xie X; Kong Y; Song C; Qiu X; Xiao X
    Front Pharmacol; 2018; 9():1248. PubMed ID: 30505272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of lncRNA AFAP1-AS1 by oridonin inhibits the epithelial-to-mesenchymal transition and proliferation of pancreatic cancer cells.
    Lou S; Xu J; Wang B; Li S; Ren J; Hu Z; Xu B; Luo F
    Acta Biochim Biophys Sin (Shanghai); 2019 Aug; 51(8):814-825. PubMed ID: 31314060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA AFAP1-AS1 facilitates tumor growth and promotes metastasis in colorectal cancer.
    Han X; Wang L; Ning Y; Li S; Wang Z
    Biol Res; 2016 Aug; 49(1):36. PubMed ID: 27578191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Noncoding RNA AFAP1-AS1 Promoted Tumor Growth and Invasion in Cholangiocarcinoma.
    Lu X; Zhou C; Li R; Deng Y; Zhao L; Zhai W
    Cell Physiol Biochem; 2017; 42(1):222-230. PubMed ID: 28535506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of lncRNA AFAP1-AS1 promotes cell proliferation and invasion in gastric cancer.
    Li Z; Ding Z; Rong D; Tang W; Cao H
    Oncol Lett; 2019 Sep; 18(3):3211-3217. PubMed ID: 31452798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Expression of lncRNA AFAP1-AS1 Promotes the Progression of Colon Cancer and Predicts Poor Prognosis.
    Bo H; Fan L; Li J; Liu Z; Zhang S; Shi L; Guo C; Li X; Liao Q; Zhang W; Zhou M; Xiang B; Li X; Li G; Xiong W; Zeng Z; Xiong F; Gong Z
    J Cancer; 2018; 9(24):4677-4683. PubMed ID: 30588252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of lncRNA AFAP1-AS1 correlates with poor prognosis and promotes tumorigenesis in colorectal cancer.
    Wang F; Ni H; Sun F; Li M; Chen L
    Biomed Pharmacother; 2016 Jul; 81():152-159. PubMed ID: 27261589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA AFAP1-AS1 Supresses miR-139-5p and Promotes Cell Proliferation and Chemotherapy Resistance of Non-small Cell Lung Cancer by Competitively Upregulating RRM2.
    Huang N; Guo W; Ren K; Li W; Jiang Y; Sun J; Dai W; Zhao W
    Front Oncol; 2019; 9():1103. PubMed ID: 31696057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing of lncRNA AFAP1-AS1 Inhibits Cell Growth and Metastasis in Clear Cell Renal Cell Carcinoma.
    Mu Z; Dong D; Wei N; Sun M; Wang W; Shao Y; Gao J; Yin P; Zhao C
    Oncol Res; 2019 Jun; 27(6):653-661. PubMed ID: 30832752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.